Fueling innovation globally through trusted relationships
Speak to our teamClarivate Consulting Services lies at the center of our unique combination of steadfast industry expertise, high-quality data, and innovative technology applications. Through harnessing these capabilities, Clarivate consultants can get you the answers you need in a way that makes sense to your organization.
Whether you work in life sciences, academia, government, legal services, or corporate, Clarivate consultants have first-hand experience with the struggles you’re faced with every day. We work with you to understand your challenges, plan and deliver a tailored solution, and continue to support you any way you need to make confident decisions and achieve your organizational objectives.
In today’s global research environment, academic, government and non-profit institutions must demonstrate research excellence and the broader socioeconomic outcomes of investments in research. Our consultants help you make data-informed decisions throughout the research lifecycle, from strategic planning through to outcomes assessment.
Biopharma faces an increasingly intricate drug lifecycle to successfully deliver patients life-saving therapies. Our consultants help you traverse each step of drug development – from discovery to commercialization – to bring treatments to market and patients faster.
In the dynamic medtech market, medical device companies need to evolve their commercialization strategies regularly to keep up with the demands of customer influences. Our consultants make it easy to manage the product lifecycle and strategically plan your portfolio, launch, commercial or market access strategies.
The IP lifecycle involves complex processes that require seamless collaboration across multiple teams. Our consultants work with you to create flexible solutions that help optimize workflows across the entire IP lifecycle, empowering you to maximize internal resources and create operational efficiencies while reducing risk.
Every touchpoint is an opportunity to delight or disappoint a customer. Knowing what is and isn’t working for them is key to your organization’s operational and financial success. Our consultants help you implement customer experience and customer journey mapping programs to drive deeper customer insights and ultimately achieve higher revenue, better retention rates and improved margins.
Rick Finch
Senior Vice President, Life Sciences Global Consulting
Rick has more than 20 years of experience leading Life Science consulting groups. Prior to Clarivate, Rick held senior executive roles at several leading and innovative companies, including Accenture, where he was a Managing Director and Global Head of all commercial consulting engagements for a top 5 global pharmaceutical company. While at Accenture, he also led Digital Consulting for the Product Industry Group that included life sciences, consumer goods and retail clients. Rick was Senior Vice President of Industry Solutions for Outcome Health, a private equity-backed start-up, where he led sales efforts with life sciences and healthcare customers for the company’s point-of-care solutions.
Nadine Schissel
CX Services Practice Leader
Nadine is a customer experience leader with more than 25 years experience building companies and consulting with a focus on delivering measurable results while enhancing customer and employee engagement and loyalty. Ability to translate experience management theory into practical actions. Expertise in organization effectiveness helps clients align culture, behavior and systems to make customer experience management a business discipline.
Annya Dushine
Solutions Architect
Annya has more than 20 years of expertise providing law firms and corporate legal departments with strategic and practical consulting services in all aspects of IP portfolio and operations management. Annya’s expertise includes helping clients to improve efficiency, reduce risk, maximize resources and increase profitability. Annya has established and managed IP departments at several corporations and law firms, developing optimal organizational models and IP business processes, implementing IP asset management systems, and establishing the necessary controls to ensure compliance to US and International IP Law.
John Lebbos, MD
Partner, Business Development & Licensing Consulting
John has over 20 years of experience supporting clients in portfolio, product and commercial strategy, and in various areas related to transaction advisory, including, but not limited to, product and therapeutic area strategy, opportunity and market assessments, disease area analysis, sales forecasting, and commercial due diligence. Formerly a Vice President in DRG’s syndicated research group, John, received his medical degree from the University of Massachusetts. Prior to pursuing his medical degree, he attended Tufts University where he graduated summa cum laude in chemical engineering.
Alison Kneen
Senior Vice President, Global Market Access
Alison is a recognized global expert in all aspects of market access and reimbursement strategies built over 35 years’ experience in the pharmaceutical industry with 28 years’ specific to market access. Upon joining DRG Abacus, now a part of Clarivate, in 2018, Alison established the Global Access Advisory to provide strategic end-to-end guidance for clients navigating the roadmap to market access. An inaugural member of the first market access team in the pharmaceutical industry, Alison further developed her career at GSK, Novartis, AstraZeneca, and Baxalta, holding senior leadership positions at Local, European, and Global levels.
Phile Govaert
Partner, Academic & Government Consulting
Phile has over 25 years of experience in consulting and commercial roles. He brings a wide variety of experience and engagements all levels within libraries but also at the office of research supporting them with their strategic and tactical challenges in this highly competitive environment. Prior to joining Clarivate, Phile spent over 10 years at Elsevier where he led academia, government and corporate sales. He also spent over 7 years at Arthur D. Little where he led the corporate finance and M&A practice of the Benelux. Next to that he worked for ProQuest and Boer & Croon driving business across the academic, government, and life sciences industries.